Study Evaluating the Efficacy and Safety With CAR-T for Recurrent or Refractory Acute Non T Lymphocyte Leukemia

NCT02735291 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Leukemia

Interventions

BIOLOGICAL: CD19-targeted CAR-T cells

Sponsor

Sinobioway Cell Therapy Co., Ltd.

Collaborators

[object Object]